News

Net profit of Syncom Formulations (India) rose 42.28% to Rs 25.17 crore in the quarter ended March 2026 as against Rs 17.69 crore during the previous quarter ended March 2025. Sales declined 9.05% to Rs 135.41 crore in the quarter ended March 2026 as against Rs 148.88 crore during the previous quarter ended March 2025.For the full year,net profit rose 54.64% to Rs 76.44 crore in the year ended March 2026 as against Rs 49.43 crore during the previous year ended March 2025. Sales rose 5.20% to Rs 489.17 crore in the year ended March 2026 as against Rs 465.01 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales135.41148.88 -9 489.17465.01 5 OPM %16.2511.92 -15.8311.64 - PBDT36.1824.58 47 107.6170.70 52 PBT33.7023.29 45 101.0865.50 54 NP25.1717.69 42 76.4449.43 55 Powered by Capital Market - Live News

Net profit of Syncom Formulations (India) rose 40.40% to Rs 24.57 crore in the quarter ended March 2026 as against Rs 17.50 crore during the previous quarter ended March 2025. Sales declined 9.74% to Rs 134.00 crore in the quarter ended March 2026 as against Rs 148.46 crore during the previous quarter ended March 2025.For the full year,net profit rose 55.54% to Rs 76.01 crore in the year ended March 2026 as against Rs 48.87 crore during the previous year ended March 2025. Sales rose 5.12% to Rs 486.57 crore in the year ended March 2026 as against Rs 462.85 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales134.00148.46 -10 486.57462.85 5 OPM %16.0311.77 -15.8611.56 - PBDT35.3424.28 46 107.0169.83 53 PBT32.8622.99 43 100.4864.64 55 NP24.5717.50 40 76.0148.87 56 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 22 May 2026.

Net profit of Syncom Formulations (India) rose 45.46% to Rs 18.91 crore in the quarter ended December 2025 as against Rs 13.00 crore during the previous quarter ended December 2024. Sales declined 9.72% to Rs 115.14 crore in the quarter ended December 2025 as against Rs 127.53 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales115.14127.53 -10 OPM %18.4211.55 - PBDT26.4518.57 42 PBT25.0917.26 45 NP18.9113.00 45 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News